{"id":13375,"date":"2016-01-12T12:53:07","date_gmt":"2016-01-12T17:53:07","guid":{"rendered":"http:\/\/www.aidslaw.ca\/site\/?p=13375"},"modified":"2024-07-23T08:58:54","modified_gmt":"2024-07-23T12:58:54","slug":"factum-of-the-interveners-at-the-supreme-court-of-canada-r-v-lloyd","status":"publish","type":"publication22","link":"https:\/\/www.hivlegalnetwork.ca\/site\/factum-of-the-interveners-at-the-supreme-court-of-canada-r-v-lloyd\/","title":{"rendered":"Factum of the Interveners at the Supreme Court of Canada: R. v. Lloyd"},"content":{"rendered":"&#8221;Globally, prisons disproportionately incarcerate people from marginalized communities, who, in turn, are disproportionately affected by conditions such as drug dependence, HIV, and hepatitis C virus. &#8230;\u00a0Section 5(3)(a)(i)(D) of the <i>Controlled Drugs and Substances Act<\/i>\u00a0(the \u201cMMS Provision\u201d) mandates that the persons to whom it applies serve a one year prison sentence, whatever their health condition. The MMS Provision thereby jeopardizes the health of people who use drugs, particularly those living with HIV and\/or HCV, and public health more broadly. &#8230;\u00a0The Coalition\u00a0intervenes with respect to each of the constitutional questions at issue in\u00a0this appeal. The Coalition submits that the MMS Provision violates ss. 7 and 12 of the <i>Charter<\/i>, and that those violations cannot be justified under s. 1.&#8221;<\/p>\n<p>Interveners: HIV\u00a0&amp; AIDS Legal Clinic (Ontario), Canadian HIV\/AIDS Legal Network,\u00a0British Columbia Centre for Excellence in HIV\/AIDS, Prisoners with HIV\/AIDS Support Action Network (PASAN), and\u00a0Canadian Association of People Who Use Drugs<\/p>\n<p class=\"download-link-button\"><a class=\"download-link en\" title=\"Factum of the Interveners at the Supreme Court of Canada: R. v. Lloyd\" href=\"https:\/\/www.hivlegalnetwork.ca\/site\/download\/13443\/?tmstv=1776402099\" rel=\"nofollow\">\r\n\tDownload<\/a><\/p>","protected":false},"author":1,"featured_media":0,"menu_order":0,"template":"","meta":{"_acf_changed":false,"footnotes":""},"publication_topics":[146,147,201,155],"publication_type":[170],"publication_language":[184],"class_list":["post-13375","publication22","type-publication22","status-publish","hentry","publication_topics-discrimination","publication_topics-drug-policy","publication_topics-hepatitis-c","publication_topics-prisons","publication_type-advocacy","publication_language-english"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/13375","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22"}],"about":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/types\/publication22"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":8,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/13375\/revisions"}],"predecessor-version":[{"id":21531,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/13375\/revisions\/21531"}],"wp:attachment":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/media?parent=13375"}],"wp:term":[{"taxonomy":"publication_topics","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_topics?post=13375"},{"taxonomy":"publication_type","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_type?post=13375"},{"taxonomy":"publication_language","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_language?post=13375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}